The Manufacturer and Distributor Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $49.00

CEC Hours: 1

Order Webinar

  

Re-engineering the Health Care Supply Chain: A CQO Thought Leader Discussion Series” is hosted by AHRMM's Cost, Quality and Outcomes (CQO) Movement sponsors. This webinar series focuses on how the health care supply chain will evolve and be more resilient in the post-pandemic environment.

The resiliency of the health care supply chain is interdependent upon the resiliency of the manufacturer and distributor supply chain. In the first webinar of the series, distributor and manufacturer panelists discuss their changing strategies relating to COVID-19 lessons, domestic versus international production and ways providers, distributors and manufacturers need to work together moving forward.

For future webinars in this series, visit the AHRMM Calendar.

 

Moderator: Karen Conway, Vice President, Healthcare Value, GHX

Panelists:

  • Christine Arme, Vice President Healthcare Systems & Strategic Channels, Medical Solutions Division, 3M Health Care Business Group
  • Lisa Hohman, CEO, Concordance Healthcare Solutions
  • Ruben Taborda, Senior Director, Hospital and Distributor Supply Chain Solutions, Johnson & Johnson

 

Download the Survey Results

Download the Summary

 

 

Sponsored By:

CQO Sponsors

Related Resources

White Papers
This paper examines the journey that an organization travels to arrive at an outsource decision and the challenges that it should be alert to
White Papers
The paper presents healthcare supply chain tools and strategies for navigating the Cost, Quality, and Outcomes (CQO) Movement, and explores new ini
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Toolkits/Methodology
How-to guide to managing IV disruptions.